These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17689128)

  • 1. Serum ghrelin levels but not GH, IGF-1 and IGFBP-3 levels are altered in patients with fibromyalgia syndrome.
    Tander B; Atmaca A; Aliyazicioglu Y; Canturk F
    Joint Bone Spine; 2007 Oct; 74(5):477-81. PubMed ID: 17689128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of leptin, growth hormone, and insulin-like growth factor levels with body mass index and disease severity in patients with fibromyalgia syndrome.
    Koca TT; Berk E; Seyithanoğlu M; Koçyiğit BF; Demirel A
    Acta Neurol Belg; 2020 Jun; 120(3):595-599. PubMed ID: 30547374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effects of ghrelin on insulin secretion and glucose disposal rate in gastrectomized patients.
    Damjanovic SS; Lalic NM; Pesko PM; Petakov MS; Jotic A; Miljic D; Lalic KS; Lukic L; Djurovic M; Djukic VB
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2574-81. PubMed ID: 16621911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lowered ghrelin levels in acromegaly—normalization after treatment].
    Kozakowski J; Rabijewski M; Zgliczyński W
    Endokrynol Pol; 2005; 56(6):862-70. PubMed ID: 16821203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low plasma ghrelin level in gastrectomized patients is accompanied by enhanced sensitivity to the ghrelin-induced growth hormone release.
    Popovic V; Miljic D; Pekic S; Pesko P; Djurovic M; Doknic M; Damjanovic S; Micic D; Cvijovic G; Glodic J; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2187-91. PubMed ID: 15644398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estradiol potentiates ghrelin-stimulated pulsatile growth hormone secretion in postmenopausal women.
    Veldhuis JD; Keenan DM; Iranmanesh A; Mielke K; Miles JM; Bowers CY
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3559-65. PubMed ID: 16804038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ghrelin, IGF-I and IGFBP-3 levels in children with type 1 diabetes mellitus.
    Bideci A; Camurdan MO; Cinaz P; Demirel F
    J Pediatr Endocrinol Metab; 2005 Dec; 18(12):1433-9. PubMed ID: 16459470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of active and total ghrelin in renal failure: a relationship with GH/IGF-I axis.
    Jarkovská Z; Hodková M; Sazamová M; Rosická M; Dusilová-Sulková S; Marek J; Justová V; Lacinová Z; Haluzík M; Haas T; Krsek M
    Growth Horm IGF Res; 2005 Dec; 15(6):369-76. PubMed ID: 16198134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3.
    Juul A; Kastrup KW; Pedersen SA; Skakkebaek NE
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone and insulin-like growth factor-1 concentrations in women with fibromyalgia.
    McCall-Hosenfeld JS; Goldenberg DL; Hurwitz S; Adler GK
    J Rheumatol; 2003 Apr; 30(4):809-14. PubMed ID: 12672204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ghrelin, leptin, IGF-1, IGFBP-3, and insulin concentrations at birth: is there a relationship with fetal growth and neonatal anthropometry?
    Chiesa C; Osborn JF; Haass C; Natale F; Spinelli M; Scapillati E; Spinelli A; Pacifico L
    Clin Chem; 2008 Mar; 54(3):550-8. PubMed ID: 18202160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The growth hormone (GH)-releasing hormone-GH-insulin-like growth factor-1 axis in patients with fibromyalgia syndrome.
    Leal-Cerro A; Povedano J; Astorga R; Gonzalez M; Silva H; Garcia-Pesquera F; Casanueva FF; Dieguez C
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3378-81. PubMed ID: 10487713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ghrelin concentrations in healthy children and adolescents.
    Whatmore AJ; Hall CM; Jones J; Westwood M; Clayton PE
    Clin Endocrinol (Oxf); 2003 Nov; 59(5):649-54. PubMed ID: 14616891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of chronic Naltrexone treatment on growth hormone and insulin secretion in obese subjects.
    De Marinis L; Mancini A; Valle D; Bianchi A; De Luca AM; Fulghesu AM; Villa P; Mancuso S; Lanzone A
    Int J Obes Relat Metab Disord; 1997 Nov; 21(11):1076-81. PubMed ID: 9368834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of menopause and different combined estradiol-progestin regimens on basal and growth hormone-releasing hormone-stimulated serum growth hormone, insulin-like growth factor-1, insulin-like growth factor binding protein (IGFBP)-1, and IGFBP-3 levels.
    Cano A; Castelo-Branco C; Tarín JJ
    Fertil Steril; 1999 Feb; 71(2):261-7. PubMed ID: 9988395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a high-protein diet on ghrelin, growth hormone, and insulin-like growth factor-I and binding proteins 1 and 3 in subjects with type 2 diabetes mellitus.
    Gannon MC; Nuttall FQ
    Metabolism; 2011 Sep; 60(9):1300-11. PubMed ID: 21406307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in total ghrelin within the somatotropic axis in severe burn patients: comparison of those with inhalation injury and those without inhalation injury.
    Lee BW; Park SH; Ihm SH; Kim JH; Kim DH; You KC; Kim SW; Yoo HJ
    Growth Horm IGF Res; 2008 Aug; 18(4):291-7. PubMed ID: 18178497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
    Khorram O; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chronic treatment with octreotide nasal powder on serum levels of growth hormone, insulin-like growth factor I, insulin-like growth factor binding proteins 1 and 3 in acromegalic patients.
    Invitti C; Fatti L; Camboni MG; Porcu L; Danesi L; Delitala G; Cavagnini F
    J Endocrinol Invest; 1996 Sep; 19(8):548-55. PubMed ID: 8905479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma ghrelin levels in patients with end-stage renal disease.
    Jarkovská Z; Rosická M; Krsek M; Sulková S; Haluzík M; Justová V; Lacinová Z; Marek J
    Physiol Res; 2005; 54(4):403-8. PubMed ID: 15588149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.